CIK 0001721484
- Emerging growth company
Longeveron Inc.
Sign in to watch- Ticker
- LGVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472174146
- Phone
- +1 305-302-7158
- Business address
- 1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
- Former names
- LONGEVERON LLC
- 4 Shares withheld for taxes CFO and Treasurer gave up 1,288 shares (to pay taxes)
- 4 Grant or award Chief Medical Officer acquired 152,335 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes CFO and Treasurer gave up 1,736 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel, Secretary gave up 3,316 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 3,979 shares (to pay taxes)
- 4 Open-market buy Chief Scientific Officer bought 2,500 shares at $3.69 ($9,225)
- 4 Open-market buy CEO bought 1,000 shares at $3.81 ($3,810)
- 4 Open-market buy Director bought 19,900 shares at an average $3.66 ($72,855)
- 4 Open-market buy CFO and Treasurer bought 5,000 shares at $3.34 ($16,700)
- 4 Open-market buy General Counsel, Secretary bought 1,750 shares at $3.34 ($5,845)
- 4 Open-market buy Chief Scientific Officer bought 5,000 shares at an average $3.39 ($16,930)
- 4 Shares withheld for taxes General Counsel, Secretary gave up 38,752 shares (to pay taxes)
- 4 Shares withheld for taxes CFO and Treasurer gave up 19,052 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 43,929 shares (to pay taxes)
- 4 Grant or award CEO acquired 8,223 shares (grant or award)
- 4 Grant or award General Counsel, Secretary acquired 6,167 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 12,335 shares (grant or award)
Page 11 of 13 · 246 filings